YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 24, 16:00
4791.15
-4.85 (-0.1%)
VOLUME 35,208
LIVE
NSE
Sep 24, 15:59
4790.35
-6.95 (-0.14%)
VOLUME 251,615
News on Dr Reddys Laboratories
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sputnik Light single-dose vaccine launch in India may get delayed

3.01 pm | 16 Sep 2021 |  Source: Moneycontrol.com

An expert panel of the Central Drugs Standard Control Organisation asks company to conduct Phase-3 immune-bridging clinical trials on Indian populatio...

Buy Dr Reddy’s Laboratories: target of Rs 5900: Sharekhan

1.03 pm | 07 Sep 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 5900 in its research report dated ...

Dr Reddy's Laboratories shares rise 3% on drug launch in Canada

9.54 am | 02 Sep 2021 |  Source: Moneycontrol.com

The share touched a 52-week high of Rs 5,613.65 and a 52-week low of Rs 4,135.90 on 07 July, 2021 and 19 March, 2021, respectively....

Dr Reddy's launches generic stomach ulcer drug in US market

3.02 pm | 31 Aug 2021 |  Source: PTI

The company has launched Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules USP, 5 mg/2.5 mg in the US market, Dr Reddy's Laboratories ...

Hold Dr Reddy’s Laboratories: target of Rs 5250: ICICI Direct

11.27 am | 02 Aug 2021 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Dr Reddy’s Laboratories with a target price of Rs 5250 in its research report dated July 28, 2021....

Dr Reddy’s: Growth story remains intact; margins key monitorable

11.43 am | 28 Jul 2021 |  Source: Moneycontrol.com

Dr Reddy's margins are likely to be weighed by recurring investments - digitization, brand building exercise & elevated R&D - in near to medium te...

Dr Reddys Labs Consolidated June 2021 Net Sales at Rs 4,945.10 crore, up 11.72% Y-o-Y

7.22 pm | 27 Jul 2021 |  Source: Moneycontrol.com

NULL...

Dr Reddys Labs Standalone June 2021 Net Sales at Rs 3,433.50 crore, up 5.83% Y-o-Y

7.11 pm | 27 Jul 2021 |  Source: Moneycontrol.com

NULL...

Dr Reddy's Q1 results: Profit falls 1.5% to Rs 570.8 crore, revenue increases 11.4%

11.39 am | 27 Jul 2021 |  Source: Moneycontrol.com

Dr Reddy's Q1 results: Earnings miss expectations as profit was estimated at Rs 700 crore on a revenue of Rs 4,991.4 crore. Global generics busine...

Dr. Reddy’s Laboratories Q1 PAT seen up 10.2% YoY to Rs 655.4 cr: KRChoksey

11.37 am | 13 Jul 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 19.1 percent Y-o-Y (up 10.5 percent Q-o-Q) to Rs 5,270.1 crore, according to KRChoksey....

Dr Reddy’s Q1 PAT seen up 5.4% YoY to Rs 626.7 cr: ICICI Direct

7.56 pm | 12 Jul 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 10.9 percent Y-o-Y (up 3 percent Q-o-Q) to Rs 4,910.8 crore, according to ICICI Direct....

Dr Reddy’s: COVID opportunity gets wings

10.39 am | 17 May 2021 |  Source: Moneycontrol.com

Along with Sputnik V and 2-DG, Dr Reddys has further strengthened its COVID opportunity, which makes it a worthy watch...

Dr Reddys Labs Consolidated March 2021 Net Sales at Rs 4,768.20 crore, up 7.18% Y-o-Y

8.11 pm | 14 May 2021 |  Source: Moneycontrol.com

NULL...

Dr Reddys Labs Standalone March 2021 Net Sales at Rs 3,350.70 crore, up 17.5% Y-o-Y

8.00 pm | 14 May 2021 |  Source: Moneycontrol.com

NULL...

Dr Reddy's Labs Q4 profit falls 27.6% on muted US business, misses estimates

1.02 pm | 14 May 2021 |  Source: Moneycontrol.com

In the financial year FY21, consolidated profit dropped 1.8 percent to Rs 1,914.9 crore and revenue grew by 8.7 percent to Rs 18,972.2 crore compared ...

Dr Reddy's Labs to announce Q4 numbers today, here's what brokerages expect

11.38 am | 14 May 2021 |  Source: Moneycontrol.com

The company is expected to report double-digit growth in revenue on the back of the Wockhardt acquisition and good business in India and Europe but a ...

Accumulate Dr Reddy's Laboratories; target of Rs 5400: Dolat Capital Market

1.46 pm | 13 Apr 2021 |  Source: Moneycontrol.com

Dolat Capital Market recommended accumulate rating on Dr. Reddy's Laboratories with a target price of Rs 5400 in its research report dated April 1...

Dr Reddy’s Lab Q4 PAT may dip 13.6% YoY to Rs. 674.5 cr: Sharekhan

8.42 pm | 12 Apr 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 9 percent Y-o-Y (down 1.9 percent Q-o-Q) to Rs. 4,849.3 crore, according to Sharekhan....

1 2 3
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.